BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 5841669)

  • 1. [Efficacy in the bronchitic syndrome of an orciprenaline-calcium iodide combination].
    Tolva D; Benati E
    Minerva Med; 1965 Oct; 56(85):3622-5. PubMed ID: 5841669
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticholinergic and beta-sympathomimetic inhalation challenges in asthma and bronchitis.
    Marcq M; Minette A
    Acta Tuberc Pneumol Belg; 1976; 67(3-4):156-62. PubMed ID: 1016524
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of the action of beta-sympathomimetic bronchodilator agents in chronic obstructive pneumopathy].
    Racoveanu C; Manicatide M
    Stud Cercet Med Interna; 1971; 12(2):151-60. PubMed ID: 5565346
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the value and effectiveness of the use of an association of an isoproterenol derivative and calcium iodide in respiratory tract diseases in the aged].
    Barbieri R; Michetti A
    Minerva Med; 1971 May; 62(36):1858-69. PubMed ID: 5580497
    [No Abstract]   [Full Text] [Related]  

  • 5. The bronchodilator effects of orciprenaline and salbutamol: a double-blind study.
    Racoveanu C; Stanescu DC; Manicatide M; Stroescu V
    Bull Physiopathol Respir (Nancy); 1970; 6(4):809-18. PubMed ID: 4940888
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contribution to the knowledge of a new bronchodilator].
    Sequi G; Coltro L
    Folia Med (Napoli); 1966 Mar; 49(3):213-9. PubMed ID: 5912517
    [No Abstract]   [Full Text] [Related]  

  • 7. A crossover comparison of isoproterenol, metaproterenol and isoetharine by spirometric determinations.
    Howard LA; Coleman M
    Ann Allergy; 1967 Sep; 25(9):512-9. PubMed ID: 4861327
    [No Abstract]   [Full Text] [Related]  

  • 8. Metaproterenol, a new bronchodilator:: comparison with isoproterenol.
    Pelz HH
    Am J Med Sci; 1967 Mar; 253(3):321-4. PubMed ID: 6021691
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bronchospasmolytic and extrabronchial action of Berotec (Fenoterol, Th 1165) in patients with asthma or chronic bronchitis with bronchial spasm].
    Rozniecki J; Grabski W
    Pol Tyg Lek; 1975 Feb; 30(7):301-4. PubMed ID: 1118349
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of spastic bronchitis with a new bronchospasmolytic agent].
    Heller K
    Wien Med Wochenschr; 1972 Oct; 122(42):606-9. PubMed ID: 5081450
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experiences with a new drug association with anti-asthmatic action].
    Martelli A
    Clin Ter; 1967 Jun; 41(6):529-44. PubMed ID: 4387419
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of Tranquo-Alupent in asthmatic syndrome].
    Gentschy E; Ott N
    Ther Ggw; 1969 Sep; 108(9):1298 passim. PubMed ID: 4910102
    [No Abstract]   [Full Text] [Related]  

  • 13. [1-second value and oscillatory airway resistance in the evaluation of the effectiveness of beta-adrenergic agents under general practice conditions].
    Kropp R; Aurich R
    Prax Klin Pneumol; 1983 Nov; 37(11):1178-83. PubMed ID: 6361723
    [No Abstract]   [Full Text] [Related]  

  • 14. [Observations on the use of a sympathomimetic aerosol for diagnostic and therapeutic use].
    Gaffuri E; Reggiani A
    Clin Ter; 1967 Dec; 43(6):559-65. PubMed ID: 5617981
    [No Abstract]   [Full Text] [Related]  

  • 15. [New beta-adrenergic receptor stimulators in the symptomatic treatment of asthma and chronic obstructive bronchial diseases].
    Van Der Straeten M; Lamont H; Pauwels R; Tasson J
    Acta Tuberc Pneumol Belg; 1974; 65(3-4):384-94. PubMed ID: 4156900
    [No Abstract]   [Full Text] [Related]  

  • 16. The bronchodilator effects of orciprenaline and salbutamol. A double-blind study.
    Racoveanu C; Stanescu DC; Manicatide M; Stroescu V
    Postgrad Med J; 1971 Mar; 47():Suppl:83-6. PubMed ID: 4929399
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of the Tranquo-Alupent test in patients with chronic asthmatoid bronchitis].
    Schildwächter G; Böhlau V
    Med Monatsschr; 1969 Oct; 23(10):459-61. PubMed ID: 5346123
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anticholinergic agents as bronchodilator agents. Significance of acetylcholine as a bronchoconstrictor transmitter agent in airway obstruction].
    Ulmer WT; Dorsch J; Iravani J; Schüler KG; Stempel G; Vastag E
    Arzneimittelforschung; 1973 Mar; 23(3):468-76. PubMed ID: 4740138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanism of action and indications for administration of some bronchodilator agents].
    Nikodýmová L; Růzicka J
    Cas Lek Cesk; 1971 Oct; 110(41):945-50. PubMed ID: 5112128
    [No Abstract]   [Full Text] [Related]  

  • 20. [New isoprenaline-derivative (1-(3,5-dihydroxyphenyl)-1-hydroxy-2-1(4-hydroxyphenyl)-isopropyl-aminoethane. Th 1165 a) in therapy of acute cardiovascular and respiratory emergencies].
    Schuster HP; Baum P
    Arzneimittelforschung; 1969 Dec; 19(12):1905-14. PubMed ID: 4393611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.